Network Model
The network model of a database is an improvement over the hierarchical model.4 In the network database model, a single object can point to many other objects, with the reverse also being true e.g., an object child E can have several parents - A and B Figure 3 . While these complex relationships improve the access to desired records, the inherent clarity of the hierarchical system is lost through the complexity of the database organization. As a consequence, design and navigational data access...
Analysis of Genetic Variations
The generic genome of a species is responsible for all the common traits shared by the members of the species. In this section, we focus on the slight but important differences between these members that promote them to genomic individuals. In humans, these differences are responsible for distinctions in appearance, and, more importantly, for individual predispositions to diseases and responses to certain drugs. In the same context, the individual genomic differences of the infectious agents...
Conclusion Psa
Aberrant cell-signaling cascades generally lead to the generation of dominant expression of single regulatory protein, increasing the proliferation of the cell as well as the potential of the capacity for tissue invasion. The equilibrium between apoptosis and survival leads to resistance to classical chemotherapy as well as radiotherapy. A better knowledge of cell-signaling pathways leading to highly specific compounds that can be used with traditional therapies is therefore of utmost...
Small Molecule Libraries in Chemical Biology
Availability of a large quantity of high-quality small molecules is essential for a successful chemical biology program. Access to quality compounds outside of the vast proprietary small molecule libraries owned by large pharmaceutical companies has increased substantially over the past decade. Use of compound collections from both commercial and federal sources is becoming more widespread. 3.07.2.1.1 Commercially available collections A large number of commercial suppliers offer compound...
Analysis
Analysis of the purified protein prior to crystallization or NMR spectroscopy is essential. During the purification procedure, different stress factors act upon the protein of interest. Proteases may degrade the protein intermolecular disulfide bridges and protein aggregation may disturb structure studies. For those reasons, the degree of purity, correct folding, sequence, and aggregation status together with the activity of the enzyme must all be tested. Programs calculating physicochemical...
ClusterBased Compound Selection
Clustering is the process of dividing a collection of objects into groups or clusters such that the objects within a cluster are highly similar whereas objects in different clusters are dissimilar see Figure 9a .139 Clustering therefore Figure 8 a Dissimilarity-based compound selection using the MaxMin function with the order in which the compounds would be selected green . b A sphere exclusion algorithm again the order in which compounds would be selected is shown. Figure 9 a The grouping of...
Purification
After producing the proteins of interest in suitable expression systems or after gaining sufficient amounts from natural sources, the protein of interest must then be separated from any contaminating substances such as sugars, lipids, and or Figure 3 Wave Bioreactor System Wave Biotech AG the figure shows a cell bag filled with medium and cells on a wave bioreactor rocking platform. Sterile cellbag - Sampling device Temperature control Figure 3 Wave Bioreactor System Wave Biotech AG the figure...
References Ezn
1. American Chemical Society, CAS Online SciFinder. http www.cas.org SCIFINDER accessed June 2006 . 2. Elsevier MDL, CrossFire Beilstein Database. http www.beilstein.com accessed June 2006 . 3. InfoChem GmbH, M nchen, Spresi Database. http www.spresiweb.de accessed June 2006 . 4. Daylight Chemical Information System, Inc., Santa Fe, USA. http www.daylight.com accessed June 2006 . 5. Elsevier MDL, MDDR - MDL Drug Data Report. data report accessed June 2006 . 6. Prous Science, Barcelona, Spain....
eMolecules
Started by eMolecules, Inc., this160 is a new free open-access search engine for chemistry-related information. Its mission is to discover, curate, and index all of the public chemical information in the world, and make it available to the public. eMolecules distinguishes itself by extremely fast searches, an appealing presentation of results, and high-quality chemical drawings. Millions of molecules from hundreds of sources are merged into a single, searchable chemical database. It lets the...
Introduction Fez
The process of drug development can roughly be segmented into two phases. In the first phase, a suitable protein is searched for that is hypothesized to be the target for the drug to be developed. In the second phase, the drug molecule is selected or developed. The second phase has a much longer tradition than the first. For hundreds of years, people have searched for effective drugs. Originally, the drug that was responsible for the therapeutic effect could not be identified from the cocktail...
References Kgw
1. Peredelchuk, M. Y Bennett, G. N. Gene 1997, 187, 231-238. 2. Olson, P Zhang, Y Olsen, D. Owens, A. Cohen, P. Nguyen, K. Ye, J. J. Bass, S. Mascarenhas, D. Protein Expr. Purif. 1998, 14, 160-166. 3. Das, A. Methods Enzymol. 1990, 182, 93-112. 4. Makrides, S. C. Microbiol. Rev. 1996, 60, 512-538. 5. Hannig, G. Makrides, S. C. Trends Biotechnol. 1998, 16, 54-60. 6. Baneyx, F Curr. Opin. Biotechnol. 1999, 10, 411-421. 7. Mertens, N. Remaut, E. Fiers, W Gene 1995, 164, 9-15. 8. Donovan, R. S....
Design and Generation of Vectors for HighLevel Protein Expression in Bacteria
Vectors are generally defined as the basic vehicles that transport and deliver the target genes to be expressed into a suitable host cell. They can be relatively complicated autonomously replicating elements as plasmids, bacteriophages, or viruses or they might consist of less complex DNA molecules that integrate into the host chromosome or that are even not stable in the cellular background and provide only a transient expression of the target gene. However, common characteristics are always a...
The Cambridge Structural Database System
The distributed CSD system comprises the CSD itself together with six major software components. One of these is PreQuest, the software used by the CCDC's scientific editors to create value-added and fully checked CSD entries. This software is released so that users of the CSD system can create their own in-house databases of proprietary structures in CSD format. These private databases can be searched separately or together with the main CSD. The other five software components fall into two...
Hierarchical Database System
A hierarchical database system is the simplest type of database system. In systems of this type the various data types entities are systematically assigned to various levels Figure 2 . The hierarchical system is represented as an upside-down tree with one root segment and ordered nodes. Each parent object can have one or more children objects , but each child has only one parent. If an object has more than one parent the entity has to be duplicated in another place in the database hierarchy. In...
Molecular Networks
The analysis of molecular interactions protein-small molecule, protein-protein, protein-DNA, etc. is a central issue in bioinformatics. Molecular interactions form the basic elements in a complex biochemical circuitry that motorizes the living cell. It is important to understand the single interactions. However, a coherent picture of the workings of a cell can only come about through the understanding of the networks formed by many of these interactions. The development of appropriate models...
UbiquitineProteasome and Signal Transduction Pathways
Lysosomal proteases are mainly responsible for the degradation of proteins taken up from the cell surface and are involved in 20 of normal protein turnover. Therefore, a nonlysosomal proteolytic enzyme complex, the proteasome, degrades most cellular proteins. Proteasomes, which are localized in both the cytosol and nucleus, represent up to 1 of all cellular proteins in eukaryotes.1 It specifically degrades cytoplasmic and nuclear proteins previously tagged with Ub in an adenosine triphosphate...
Conclusion 1
Genetic engineering techniques have matured greatly in recent years, and now function as a major component of modern DDD programs. Numerous well-defined GEM and a burgeoning cohort of GER are readily available as models for both basic and applied research. Use of such models will enable us to accelerate the rate at which we dissect elemental biological mechanisms of health and disease' and develop new' rationally designed drugs to target a host of previously incurable conditions. The increasing...
i
Excessive angiogenesis high level of VEGF Figure 5 Implications of vascular endothelial growth factor receptors VEGFRs level of expression in pathologic angiogenesis. 3.10.5.2 Vascular Endothelial Growth Factor Receptors VEGFRs The VEGF family, composed of VEGF-A, VEGF-B,72 VEGF-C,73 VEGF-D,74 and placental growth factor PlGF ,75 is highly implicated in the growth and survival of the vascular endothelium. VEGF-A is a key regulator of blood vessel growth, PlGF is known to mediate arteriogenesis,...
Orthogonal LigandReceptor Pair Applications
The strategy of using small molecule-protein reengineered pairs provides powerful tools for probing the biological function of the original pair. One of the major advantages of such an approach is that only the modified system will be triggered by the altered ligand and not the natural pathway. This is of particular interest in cases where the same endogenous ligand is involved in multiple processes. This strategy may be a valuable technique for dissecting complex biological systems and...
References Aov
1. Brown, F K. Annu. Rep. Med. Chem. 1998, 33, 375-384. 2. Hann, M. Green, R. Curr. Opin. Chem. Biol. 1999, 3, 379-383. 3. Schofield, H. Wiggins, G. Willett, P. Drug Disc. Today 2001, 6, 931-934. 4. Leach, A. R. Gillet, V J. An Introduction to Chemoinformatics Kluwer Dordrecht, The Netherlands, 2003. 5. Gasteiger, J. Engel, T Chemoinformatics A Textbook Wiley-VCH Weinheim, Germany, 2003. 6. Bajorath, J. Chemoinformatics Concepts, Methods and Tools for Drug Discovery Humana Press New Jersey, NJ,...
Technical Considerations and Limitations
Despite the high potential of the technology its limits and caveats have to be understood in order to design proper experiments and in order to critically evaluate the results. Artifacts related to off-target effects have generated the need to set up stricter rules for acceptance of siRNA experiments as defined in many peer-reviewed journals. RNAi induced by long dsRNA was originally used to study gene function in plants, worms, and flies. However, when dsRNAs of more than 30 bp in length were...
Chemical Biology and Drug Discovery
The multiple examples of studies using high-throughput screening to evaluate biological process and new approaches to analyzing global responses of cells and organisms to small molecules demonstrate the breadth of chemical biology. Many of the techniques and tools of chemical biology are the same as those used in drug discovery. While the two endeavors differ somewhat in emphasis, there is unmistakable overlap between the goal of studying complex biological systems using chemical probes...
Druggability
The list of known drugs provide a means to a reverse definition of a druggable target, but in light of the genome project, and a now extended list of gene products with variable chances of being targeted with a small molecule, how do we determine a 'forward' definition of a druggable target, and triage this to a workable list In other words, can we come up with a reasonable set of criteria which is predictive of druggability and relevance to disease By way of an example, an analogy in the...
Comprehensive Medicinal Chemistry II Volume 3 Drug Discovery Technologies
Editors-in-Chief John B. Taylor and David J. Triggle ISBN 0-08-044513-6 set 3.01 Genomics, Pages 1-25, J.S. Caldwell, S.K. Chanda, J. Irelan and R. Koenig 3.02 Proteomics, Pages 27-50, H. Voshol, S. Hoving and J. van Oostrum 3.03 Pharmacogenomics, Pages 51-68, K. Lindpaintner 3.04 Biomarkers, Pages 69-85, S.E. DePrimo 3.05 Microarrays, Pages 87-106, D. Amaratunga, H. G hlmann and P.J. Peeters 3.06 Recombinant Deoxyribonucleic Acid and Protein Expression, Pages 107-128, F. Bernhard, C. Klammt...